Pactals Seoul 2018

PACTALS 2018 Poster Presentation

16:20-17:20, July 20

Poster No. Abstract Title Presenter’s Name Country
PO-001 World’s first eye language – Blink to Speak Geet Rathi India
PO-002 Disability profile and associated prognostic factors for the course of functional status in patients with Motor Neuron Disease Kavitha Andiappan Malaysia
PO-003 Exercise and ALS, putting together the pieces of the puzzle – a literature review Amruta A. Paranjape India
PO-004 Memory strategies reported by neurological patients with chronic acquired brain injury: influence of demographics and relationships to memory performance. Diana Xiaohan Huang Austrailia
PO-005 Neuropsychological characteristics of ALS patients in Korea according to revised diagnostic criteria of ALS-FTSD Jinseok Park Korea
PO-006 Comorbid frontotemporal dementia is a negative prognostic indicator in a Chinese amyotrophic lateral sclerosis cohort Tuo Ji China
PO-007 Distinct semantic agraphia in Chinese patients with ALS Bo Cui China
PO-008 The Correlation Between Cognitive Dysfunction and Depression in Korean Amyotrophic Lateral Sclerosis Patients Kang Hyun Ki Korea
PO-009 The Affecting Factors of depression in Adolescents with Chronic Illness Eungyeong Kim Korea
PO-010 Excessive Daytime Sleepiness in Chinese Patients with Sporadic Amyotrophic Lateral Sclerosis and its Association with Cognitive and Behavioural Impairments Liying Cui China
PO-011 Sleep characteristics among patients with motor neurone disease in Malaysia Ng Wan Jun Malaysia
PO-012 The SMN2 gene copy number states can affect the onset risk and survival time in Japanese ALS. Tomohiko Ishihara Japan
PO-013 Analysis of ATXN2 Trinucleotide Repeats in Korean Patients with Amyotrophic Lateral Sclerosis Young-Eun Kim Korea
PO-014 Mutations in the Calcium-dependent Protein Annexin A11 is Associated with Stress Granule Assembly in Amyotrophic Lateral Sclerosis Su Min Lim Korea
PO-015 A report of SOD1-A4V mutation in a Chinese patient with familial ALS without the A4V founder effect common in North America Lu Tang China
PO-016 Analysis of the SOD1 variants in Korean patients with amyotrophic lateral sclerosis Ki-wook Oh Korea
PO-017 Genetic and functional analysis of ANXA11 variants in a Han Chinese cohort with amyotrophic lateral sclerosis in Taiwan Pei-Chien Tsai Taiwan
PO-018 Genetic Analysis in Korean Patients with Sporadic Amyotrophic Lateral Sclerosis by Exome Sequencing Jong Eun Park Korea
PO-019 CADASIL in ALS Pyungkang Park Korea
PO-020 ALS in Mongolia : Current findings of clinic-epidemiological and molecular-genetic study Davaatseren Sergelen Mongolian
PO-021 Genetic interaction screen identifies multiple drug targets for ALS Kyoungho Suk Korea
PO-022 Deciphering Amyotrophic Lateral Sclerosis in Indonesia : A Preliminary Study by ALS Indonesia Foundation Sheila Agustini Indonesia
PO-023 Diabetes and amyotrophic lateral sclerosis incidence, a total population-based cohort study from Taiwan Charles Tzu Chi Lee Taiwan
PO-024 Geographic Differences in Clinical Features and Survival Times in Chinese Patients with Sporadic ALS Chujun Wu China
Natural history and survival relevance of ALS/MND in different phenotypes – data from a hospital-based registry Qian-qian Wei China
Incidence, prevalence, and survival of amyotrophic lateral sclerosis (ALS) in Korea, 2011-2015: using the National Health Information Database Jinseok Park Korea
PO-026 Imbalance of autophagic flux is linked to neurodegeneration Young J. Oh Korea
PO-027 Role of amlodipine protecting neural stem cells against oxygen-glucose deprivation/reoxygenation by Restoring the function of damaged mitochondria Hyun-Hee Park Korea
PO-028 A Comparative Study on the Binding Properties between Stapled p53/HDM2 and Unstapled p53/HDM2 Haeri Im Korea
PO-029 Pathological modification of TIA-1 affects stress granule dynamics in amyotrophic lateral sclerosis with SOD1 mutations Do-Yeon Lee Korea
PO-030 Microglial modification as the therapeutic strategy for Neurodegenerative diseases Min-Young Noh Korea
PO-031 Alterations in Stress Granule Dynamics are Driven by ALS-associated FUS Mutations Su Min Lim Korea
PO-032 Neuronal Expression and Function of C-type Lectin Domain Family 4 Member C, CLEC4C Minyeop Nahm Korea
PO-033 Cell type-specific roles for TBK1, a TANK binding kinase-1 at the Drosophila neuromuscular junction Minyeop Nahm Korea
PO-034 Protective Effects of Phosphatase inhibition on astrocytic TDP-43-induced Inflammation and Neurotoxicity Hyung-Jun Kim Korea
PO-035 LGR5 knockdown using small interfering RNA alters expression level of splicing factors in human neuroblastoma cells. Mina Hwang Korea
PO-036 The ALS/FTD-linked gene product, C9ORF72, regulates neuronal morphogenesis via ULK1-mediated autophagy Ho Wan Yun Singapore
PO-037 Neuroprotection of vitamin complex against oxygen-glucose deprivation-induced neural stem cell death Na-Young Choi Korea
PO-038 The effect of bee venom in an ALS animal model Eun Jin Yang Korea
PO-039 dALS2 modulate Wnt-dependent synaptic growth and neuronal survival in Drosophila Joohyung Kim Korea
PO-040 The RapGEF Gef26 regulates synaptic development via inhibition of BMP Signaling Keunjung Heo Korea
PO-041 The RacGEF Vav acts in the Rapgef2-Rap1-Rac1 pathway to regulate BMP-dependent synaptic growth through macropinocytosis Eunsang Cho Korea
PO-042 A Novel de novo ATP1A3 Mutation in Motor Neuron Disease Mimicking Rapid Onset Dystonia Parkinsonism Su Min Lim Korea
PO-043 Rab8 regulates Fasciclin II recycling to modulate synapse development Minyeop Nahm Korea
PO-044 Proteins mimicking human telomerase reverse transcriptase (hTERT) increase the survival factor of brain ischemia injury. Jeongwoo Son Korea
PO-045 Primary motor neurons are selectively myelinated by Nrg1type3-ErbB2/3 signaling in the zebrafish PNS Dong-Won Lee Korea
PO-046 Overexpression of IGFBP4 is neuroprotective in a rat model of stroke Ye Eun Kim Korea
PO-047 Identification of genetic interaction between MAP2K5 and ALS-related genes including optineurin and angiogenin Eunmi Kim Korea
PO-048 Myelin degeneration by expression of mtSOD1 contributes ALS pathogenesis Suhyun Kim Korea
PO-076 Determining molecular factors leading to enhanced aggregation propensity of Aβ42 relative to Aβ40 Yuxi Lin Korea
PO-049 Prediction of Protein Thermodynamic Parameters using Deep Learning Woohyun Kim Korea
PO-050 Clinical disease stage related changes of serological factors in amyotrophic lateral sclerosis Xueping Chen China
PO-051 Anti-acetylcholine receptor antibodies in motor neuron disease Jun Sang Yoo Korea
PO-052 Correlation of creatine kinase levels with clinical features and survival in amyotrophic lateral sclerosis Hongfei Tai China
PO-053 Serum and cerebrospinal fluid uric acid levels in patients with amyotrophic lateral sclerosis and its correlation with clinical features and survival prognosis Hongfei Tai China
PO-054 Retinal Involvement by optical coherence tomography and its correlation with disease severity in Amyotrophic lateral sclerosis Atchayaram Nalini India
PO-055 Utility of Corticospinal tract hyperintensity and Fractional anisotropy on brain MRI/ MRI-DTI as a potential biomarker in Amyotrophic lateral sclerosis Samson Nivins India
PO-056 Vestibular evoked myogenic potentials and clinical study in patients with amyotrophic lateral sclerosis Xiaoxuan Liu China
PO-057 Altered functional connectivity in early stage of ALS patients: A resting-state fMRI study Qian-qian Wei China
PO-058 Inversed TGF-beta and MCP-1 ratio as a significant biological marker predicting good responders in stem cell therapy in ALS Min-Young Noh Korea
PO-059 Muscle-related enzymes in amyotrophic lateral sclerosis Xueping Chen China
PO-060 Usefulness of diffusion tension imaging as biomarkers for amyotrophic lateral sclerosis Seol-Hee Baek Korea
PO-061 Mechanism differences of ruptured and non-ruptured carotid plaques and the role of ABCA1 Eun-Hye Lee Korea
PO-062 Safety and Efficacy of Edaravone in Delaying Functional Decline in Amyotrophic Lateral Sclerosis: A Meta-Analysis Marjorie Anne C. Bagnas Philippines
PO-063 Strategy for personalized medicine based on ALS patient-derived stem cells using CRISPR/Cas9-mediated genome editing Yeomin Yun Korea
PO-064 The effect of immunomodulatory treatment in Monoclonal Gammopathy of Undetermined Significant-associated Motor Neuron Disease Jun Sang Yoo Korea
PO-065 Prognosis of Japanese patients with amyotrophic lateral sclerosis according to motor phenotype Naoki Atsuta Japan
PO-066 Clinical features of  spinal and bulbar muscular atrophy (SBMA) Sanggon Lee Korea
PO-067 An increased LDL/HDL ratio but not non-alcoholic fatty liver disease may be protective in amyotrophic lateral sclerosis Seong-il Oh Korea
PO-068 A case of Relapsing demyelinating plaque on ALS patient Jeong Hoon Bae Korea
PO-069 Under-recognized primary spontaneous pneumothorax in Amyotrophic lateral sclerosis : a multicenter retrospective study Jin-Sung Park Korea
PO-070 Uncommon coexistence of motor neuron disease in ocular myasthenia gravis Eun Bin Cho Korea
PO-071 Unilateral hypoglossal neuropathy in multifocal acquired demyelinating sensory and motor neuropathy: Differential diagnosis of motor neuron disease Kee Hong Park Korea
PO-072 A case of PLS patient in the familial amyotrophic lateral sclerosis family Yongkyung Lee Korea
PO-073 A case of ALS-FTD Complex combined with MSA Seung Jae Kim Korea
PO-074 Hyponatremia in ALS patients would be a warning sign of respiratory failure Yong Sung Kim Korea